Skip to content

Anxiety: all studies

Page 240 of 769: studies 2,391 to 2,400 of 7,689, newest first. Back to the anxiety overview

Research

Cannabis Culture and Spirituality

Cambridge University Press eBooks March 20, 2022 Timmen Cermak

Jackson was bored with his massage therapy practice and was looking for something more interesting to do. Cannabis legalization had reawakened his interest in the use of natural, psychoactive substances as healing and spiritual agents. A once-a-month user of cannabis, he was enthusiastic about Johns Hopkins University’s research on the potential mental health benefits of psilocybin, the...

The ATENción Plena en Enfermedad de Alzheimer (ATENEA-Mindfulness in Alzheimer's Disease) Program for Caregivers: Study Protocol for a Randomized Controlled Trial.

Healthcare March 15, 2022 Alicia Sánchez-pérez, Daniel Mendialdua-Canales, Miriam Hurtado-Pomares et al.

A person affected by Alzheimer's disease (AD) gradually loses the ability to perform activities of daily living and becomes dependent on caregivers, thereby having a negative impact on the caregivers' quality of life. There is evidence that suggests that interventions aimed at caregivers, such as mindfulness, may be effective at reducing this burden and emotional issues, such as depression and...

Psychedelic Cognition—The Unreached Frontier of Psychedelic Science

Frontiers in Neuroscience March 15, 2022 Maria Bălăeţ 28 citations

Psychedelic compounds hold the promise of changing the face of neuroscience and psychiatry as we know it. There have been numerous proposals to use them to treat a range of neuropsychiatric conditions such as depression, anxiety, addiction and PTSD; and trials to date have delivered positive results in favor of the novel therapeutics. Further to the medical use, the wider healthy population is...

Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience

Frontiers in Psychiatry March 14, 2022 Edmund C. Neuhaus, George M. Slavich 14 citations

One of the most recent and potentially promising advancements in the health sciences has involved the attempted use of psychedelics for treating mental and behavioral health problems, such as anxiety, depression, posttraumatic stress disorder, and addiction. Despite surging scientific and public interest in this work, however, we presently have no standard of care or consensus regarding how...

DOI: 10.3389/fpsyt.2022.821208 (opens in new tab) Anxiety Mental health Psychotherapist Public health +1

A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders

Australian & New Zealand Journal of Psychiatry March 12, 2022 Steve Kisely, Mark Connor, Andrew A Somogyi et al. 36 citations

Objectives: There is an increasing interest in combining psilocybin or methylenedioxymethamphetamine with psychological support in treating psychiatric disorders. Although there have been several recent systematic reviews, study and participant numbers have been limited, and the field is rapidly evolving with the publication of more studies. We therefore conducted a systematic review of PubMed,...

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

Journal of Fungi March 11, 2022 Elaine Meade, Sarah Hehir, Neil J. Rowan et al. 24 citations

Mushrooms have been used as traditional medicine for millennia, fungi are the main natural source of psychedelic compounds. There is now increasing interest in using fungal active compounds such as psychedelics for alleviating symptoms of mental health disorders including major depressive disorder, anxiety, and addiction. The anxiolytic, antidepressant and anti-addictive effect of these...

Meditation and Five Precepts Mediate the Relationship between Attachment and Resilience.

Children March 7, 2022 Justin DeMaranville, Tinakon Wongpakaran, Nahathai Wongpakaran et al.

Secure attachment is fundamental to the development of resilience among adolescents. The present study investigated whether meditation and precept practices influence the relationship between attachment and resilience. This study recruited 453 10th−12th-grade boarding school students who completed the Experience of Close Relationship Questionnaire (revised), Resilience Inventory, Inner...

Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy

Frontiers in Psychology March 4, 2022 Agnieszka D. Sekula, Luke A. Downey, Prashanth Puspanathan 27 citations

Psychotherapy with the use of psychedelic substances, including psilocybin, lysergic acid diethylamide (LSD), ketamine, and 3,4-methylenedioxymethamphetamine (MDMA), has demonstrated promise in treatment of post-traumatic stress disorder (PTSD), anxiety, addiction, and treatment-resistant depression. Psychedelic-assisted psychotherapy (PP) represents a unique psychopharmacological model that...

Enhanced Resting-State Functional Connectivity With Decreased Amplitude of Low-Frequency Fluctuations of the Salience Network in Mindfulness Novices

Frontiers in Human Neuroscience March 3, 2022 Quan Gan, Ning Ding, Guoli Bi et al. 18 citations

Mindfulness and accordant interventions are often used as complementary treatments to psychological or psychosomatic problems. This has also been gradually integrated into daily lives for the promotion of psychological well-being in non-clinical populations. The experience of mindful acceptance in a non-judgmental way brought about the state, which was less interfered by a negative effect....

Home-Based Walking Meditation Decreases Disease Severity in Parkinson's Disease: A Randomized Controlled Trial.

Journal of Integrative and Complementary Medicine March 1, 2022 Witoon Mitarnun, Witid Mitranun, Wenika Mitarnun et al.

Objective: To determine the effects of walking meditation (WM) on functional performance, disease severity, and anxiety in Parkinson's disease (PD). Design: This was a randomized controlled trial. Settings: The study was conducted at a regional hospital. Subjects/Interventions: Thirty-three participants with PD were randomly allocated to the control (CON) group (n = 16) or the WM group (n =...

DOI: 10.1089/jicm.2021.0292 (opens in new tab) Full text (opens in new tab) Anxiety Aging Mind–body exercises Neurodegenerative disorders